Aphria (NYSE:APHA) announced its quarterly earnings results on Thursday. The company reported $0.05 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.05) by $0.10, Briefing.com reports. The firm had revenue of $128.60 million during the quarter, compared to the consensus estimate of $99.26 million. Aphria’s revenue for the quarter was up 971.7% on a year-over-year basis.
Shares of NYSE APHA traded up $2.13 during trading hours on Friday, hitting $7.33. The stock had a trading volume of 34,608,553 shares, compared to its average volume of 2,929,974. The firm has a market capitalization of $1.35 billion, a P/E ratio of 52.36 and a beta of 3.07. The company’s 50-day moving average price is $6.49. Aphria has a 52 week low of $3.75 and a 52 week high of $16.86.
APHA has been the subject of several recent research reports. ValuEngine raised Aphria from a “hold” rating to a “buy” rating in a research note on Thursday. CIBC cut Aphria from a “neutral” rating to a “sector underperform” rating in a research note on Friday, July 26th. Jefferies Financial Group initiated coverage on Aphria in a research note on Friday, May 24th. They issued a “buy” rating and a $11.00 price target for the company. Zacks Investment Research raised Aphria from a “strong sell” rating to a “hold” rating in a research note on Friday, May 10th. Finally, Clarus Securities initiated coverage on Aphria in a research note on Tuesday, April 16th. They issued a “buy” rating and a $22.75 price target for the company. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $14.75.
Aphria Company Profile
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.
Read More: Bear Market – How and Why They Occur
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.